1. Home
  2. DHC vs GHRS Comparison

DHC vs GHRS Comparison

Compare DHC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHC
  • GHRS
  • Stock Information
  • Founded
  • DHC 1998
  • GHRS 2018
  • Country
  • DHC United States
  • GHRS Ireland
  • Employees
  • DHC N/A
  • GHRS N/A
  • Industry
  • DHC Real Estate Investment Trusts
  • GHRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DHC Real Estate
  • GHRS Health Care
  • Exchange
  • DHC Nasdaq
  • GHRS Nasdaq
  • Market Cap
  • DHC 559.7M
  • GHRS 583.1M
  • IPO Year
  • DHC N/A
  • GHRS 2021
  • Fundamental
  • Price
  • DHC $3.02
  • GHRS $10.60
  • Analyst Decision
  • DHC Hold
  • GHRS Strong Buy
  • Analyst Count
  • DHC 3
  • GHRS 8
  • Target Price
  • DHC $4.50
  • GHRS $30.63
  • AVG Volume (30 Days)
  • DHC 923.8K
  • GHRS 146.4K
  • Earning Date
  • DHC 05-05-2025
  • GHRS 05-08-2025
  • Dividend Yield
  • DHC 1.34%
  • GHRS N/A
  • EPS Growth
  • DHC N/A
  • GHRS N/A
  • EPS
  • DHC N/A
  • GHRS N/A
  • Revenue
  • DHC $1,511,515,000.00
  • GHRS N/A
  • Revenue This Year
  • DHC $5.12
  • GHRS N/A
  • Revenue Next Year
  • DHC $6.23
  • GHRS N/A
  • P/E Ratio
  • DHC N/A
  • GHRS N/A
  • Revenue Growth
  • DHC 5.33
  • GHRS N/A
  • 52 Week Low
  • DHC $2.00
  • GHRS $6.00
  • 52 Week High
  • DHC $4.24
  • GHRS $20.50
  • Technical
  • Relative Strength Index (RSI)
  • DHC 74.73
  • GHRS 59.36
  • Support Level
  • DHC $2.15
  • GHRS $9.81
  • Resistance Level
  • DHC $3.14
  • GHRS $11.50
  • Average True Range (ATR)
  • DHC 0.17
  • GHRS 0.72
  • MACD
  • DHC 0.10
  • GHRS 0.23
  • Stochastic Oscillator
  • DHC 87.88
  • GHRS 89.60

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: